Sebia is the world’s leading provider of cutting-edge clinical protein electrophoresis technology for in-vitro diagnostic (IVD) testing. Sebia’s protein analysis systems enable the screening and monitoring of various diseases and conditions; primarily oncology (Multiple Myeloma), metabolic disorders (Diabetes) and also Hemoglobinopathy and rare pathologies.
Company’s Keywords:
2
medical devices
2019